
Windtree Therapeutics Announces Issuance of New Dual Mechanism SERCA2a Activator Patent
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) this week announced that the European Patent Office has granted Patent No. 3599243, providing patent coverage for the dual mechanism SERCA2a Activator …
Windtree Therapeutics Announces Issuance of New Dual Mechanism SERCA2a Activator Patent Read More